Literature DB >> 20819753

[Atrial septostomy in pulmonary hypertension].

Nihal Ozdemir1.   

Abstract

Despite the fact that remarkable improvements have been achieved in quality of life and survival through increasing number of specific medical treatment alternatives in severe pulmonary hypertension, many patients have resistance to medical treatment. Atrial septostomy is considered as a palliative procedure in severe pulmonary hypertension to relieve symptoms of severe pulmonary hypertension by reducing right ventricular preload and increasing systemic flow. Gradual balloon dilatation and blade balloon atrial septostomy are the most frequently used methods. If atrial septostomy is performed in experienced medical centers, it provides clinical improvement and even has tendency to extend life expectancy in patients with pulmonary hypertension resistant to medical treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20819753     DOI: 10.5152/akd.2010.127

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  2 in total

1.  NRG™ RF powered transseptal needle: a useful technique for transcatheter atrial septostomy and Fontan fenestration: report of three cases.

Authors:  Tevfik Karagöz; Alper Akın; Hayrettin Hakan Aykan
Journal:  Bosn J Basic Med Sci       Date:  2014-10-18       Impact factor: 3.363

2.  Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.

Authors:  Majdy M Idrees; Sarfraz Saleemi; M Ali Azem; Saleh Aldammas; Manal Alhazmi; Javid Khan; Abdulgafour Gari; Maha Aldabbagh; Husam Sakkijha; Abdulla Aldalaan; Khalid Alnajashi; Waleed Alhabeeb; Imran Nizami; Amjad Kouatli; May Chehab; Omar Tamimi; Hanaa Banjar; Tarek Kashour; Antonio Lopes; Omar Minai; Paul Hassoun; Qadar Pasha; Eckhard Mayer; Ghazwan Butrous; Sastry Bhagavathula; Stefano Ghio; John Swiston; Adel Boueiz; Adriano Tonelli; Robert D Levy; Marius Hoeper; Rober D Levy
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.